Canadian Investment Regulatory Organization Trade Resumption – WHY
Trading resumes in:
Company: West High Yield (W.H.Y.) Resources Ltd.
TSX-Venture Symbol: WHY
All Issues: Yes
Resumption (ET): 8:00 AM
CIRO can make a decision to impose a temporary...
Rich Checkan: Gold Nowhere Near Top, Use Price Dips to Buy
Morgan Stanley (NYSE:MS) recently recommended that investors consider a 60-20-20 portfolio where 20 percent is allocated to gold.
Rich Checkan, president and COO of...
Significant Mineralisation Confirmed In Sweden
Basin Energy (BSN:AU) has announced Significant Mineralisation Confirmed In Sweden
Download the PDF here.
This post appeared first on investingnews.com
Torchlight Innovations (Doing Business as RZOLV Technologies) Announces Preliminary Positive Results...
Torchlight Innovations Inc. (TSXV: TLX.P) (‘Torchlight’ or ‘the Company’), doing business as RZOLV Technologies, is pleased to announce positive preliminary results from its metallurgical...
Australia, US Pen Rare Earth Metals Deal in Albanese-Trump Meeting
Australian Prime Minister Anthony Albanese and US President Donald Trump signed a rare earths deal during their meeting at the White House on Monday...
Top 5 Canadian Silver Stocks of 2025
Silver’s performance in 2025 is drawing attention to silver-mining companies as investors look to gain exposure to the metal’s success.
During Q3 2025, the silver...
Cleantech Market Update: Q3 2025 in Review
The cleantech sector experienced a dynamic third quarter, with predictions of volatility coming to fruition.
While global investment in renewable energy is strong, notable...
Critical Mineral Antimony Stocks – Reshaping the Future of Defense
Investorideas.com (www.investorideas.com), a go-to platform for big investing ideas for traders, including mining and defense stocks, reports on how critical mineral antimony is gaining...
Cartier Cuts 11.0 g/t Au over 9.0 m including 30.2 g/t...
Cartier Resources Inc. (″ Cartier ″ or the ″ Company ″) (TSXV: ECR,OTC:ECRFF; FSE: 6CA) is pleased to announce the third batch of results...
Cardiol Therapeutics Completes US$11.4 Million Financing and Extends Cash Runway into...
MAVERIC Phase III pivotal trial of orphan drug candidate CardiolRx in recurrent pericarditis is fully funded through to a planned New Drug Application submission...















